News | October 13, 2021
PCI Pharma Services acquires LSNE for its CDMO business
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
The company plans to expand its portfolio in regulated markets aggressively
This product will be manufactured at Lupin’s Pithampur facility In India
The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)
DentalMonitoring, the company that pioneered artificial intelligence in dental and orthodontic care, has announced the launch of the ScanBox
The first clinical trial is expected to commence in early 2022 both in Europe and the US
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Subscribe To Our Newsletter & Stay Updated
